• SHC-1 Inhibition Elevates CFTR Membrane Abundance in Epithel

  2026-05-15

  This study demonstrates that inhibiting SHC-1, a key adaptor in the MAPK pathway, increases CFTR plasma membrane abundance in airway epithelial models, though effects are cell-type dependent. These findings clarify the context-specific regulation of CFTR trafficking and have implications for cystic fibrosis and secretory disease research.

• Bedaquiline: Diarylquinoline Antibiotic Transforming TB & Ca

  2026-05-15

  Bedaquiline’s dual targeting of tuberculosis and cancer stem cell energetics positions it as a uniquely versatile tool for advanced research. By integrating robust protocol enhancements and troubleshooting strategies, this article empowers scientists to leverage Bedaquiline across infectious disease and oncology workflows with confidence.

• Aconitase Activity Colorimetric Assay Kit: TCA Cycle Precisi

  2026-05-14

  Leverage the Aconitase Activity Colorimetric Assay Kit for rapid, high-sensitivity detection of mitochondrial aconitase activity and oxidative damage. This solution streamlines TCA cycle enzyme assays and biomarker discovery, empowering metabolic and immunometabolic research with robust, reproducible results.

• Ciprofloxacin: Mechanisms, Benchmarks, and Research Integrat

  2026-05-14

  Ciprofloxacin is a synthetic fluoroquinolone antibiotic with robust activity as a DNA gyrase and topoisomerase IV inhibitor. This article details its mechanism of action, benchmarks for antimicrobial resistance research, and critical workflow parameters for laboratory use.

• GW4064 as a Precision Tool for FXR/TLR4 Research: Beyond Lip

  2026-05-13

  Explore how GW4064, a potent non-steroidal FXR agonist, enables advanced interrogation of the FXR/TLR4 axis and ferroptosis beyond traditional lipid metabolism studies. This article delivers new insights from recent mechanistic breakthroughs, including assay design and translational implications for fibrosis and nanoparticle toxicology.

• Acridine Orange Hydrochloride: Technical Guide for Nucleic A

  2026-05-13

  Acridine Orange hydrochloride enables differential staining of DNA and RNA, supporting precise cell cycle analysis and apoptosis detection via flow cytofluorometry. This guide delineates best practices for preparation, staining, and troubleshooting to maximize assay reproducibility. Use is limited to cytochemical workflows where nucleic acid discrimination is required; it is not suited for stable, long-term solution storage or non-nucleic acid targets.

• Bortezomib (PS-341): Applied Protocols for Proteasome Inhibi

  2026-05-12

  Bortezomib (PS-341) revolutionizes apoptosis and proteostasis research with robust, reversible 20S proteasome inhibition. This guide delivers workflow enhancements, troubleshooting insights, and domain-bridging applications that empower both cancer and immunology studies.

• KX2-391 Dihydrochloride: Translational Advances in BoNT/A an

  2026-05-12

  Explore how KX2-391 dihydrochloride, also known as Tirbanibulin dihydrochloride, uniquely bridges oncology, virology, and neurotoxin research. This article elucidates new translational insights and practical assay guidance rooted in recent peer-reviewed findings.

• EdU Imaging Kits (488): Deep-Dive into Mechanisms and Biomar

  2026-05-11

  Explore the advanced science behind EdU Imaging Kits (488) for precise cell proliferation analysis. This article uniquely connects assay mechanics with biomarker-driven discoveries, providing researchers with actionable insights for S-phase DNA synthesis measurement.

• nor-Binaltorphimine Dihydrochloride: Advancing κ-Opioid Anta

  2026-05-11

  nor-Binaltorphimine dihydrochloride empowers researchers to dissect κ-opioid receptor circuits with unmatched selectivity, driving breakthroughs in pain modulation and neuropharmacology. This guide details actionable workflows, protocol enhancements, and troubleshooting strategies, translating recent circuit-mapping insights into robust, reproducible research.

• Applied Workflows with (-)-Blebbistatin: A Non-Muscle Myosin

  2026-05-10

  (-)-Blebbistatin from APExBIO empowers precise control over actin-myosin interactions, unlocking advanced cytoskeletal and cardiac research applications. This guide delivers actionable protocols, troubleshooting strategies, and insights into leveraging its selectivity for reproducible, high-impact experiments.

• ISRIB (trans-isomer): A Precision PERK Inhibitor for ER Stre

  2026-05-09

  ISRIB (trans-isomer) empowers researchers to precisely modulate the integrated stress response, enabling breakthrough applications in memory research, apoptosis assays, and neurodegenerative models. Discover protocol optimizations, troubleshooting strategies, and the latest translational insights that set this PERK inhibitor apart.

• LY-411575: Precision γ-Secretase Inhibition for Translationa

  2026-05-09

  This thought-leadership article explores the mechanistic precision and strategic potential of LY-411575, a potent γ-secretase inhibitor, for translational researchers tackling Alzheimer’s disease and cancer. Blending recent evidence from amyloid beta modulation studies with actionable protocol guidance, we dissect how LY-411575’s dual impact on amyloid and Notch pathways enables superior experimental control and translational relevance. We position APExBIO’s LY-411575 within a maturing competitive landscape and provide a visionary outlook grounded in reproducibility, specificity, and clinical insight.

• Amyloid Beta-Peptide (1-40) (human): Surface Aggregation Ins

  2026-05-08

  Explore Amyloid Beta-Peptide (1-40) (human) as a pivotal tool in Alzheimer’s disease research, with a unique focus on membrane interaction and advanced surface aggregation analytics. This article reveals novel practical implications from recent spectroscopy advances and guides optimal assay design.

• Verbascoside as a PKC/NF-κB Inhibitor: Workflow and Use-Case

  2026-05-07

  Verbascoside, a selective PKC/NF-κB inhibitor, empowers researchers to dissect inflammatory and bone metabolic signaling with exceptional specificity. This article delivers direct workflow guidance, advanced troubleshooting, and experimental insights—bridging osteoclastogenesis, neuroinflammation, and cellular signaling studies in ways other inhibitors cannot.

451 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page